Abstract: The invention relates to a multilayered interference pigment consisting of a transparent carrier material which is coated with alternating layers of colorless, non-absorbent metal oxides having a high and a low refractive index, the difference between the refractive indices being at least 0.1. The inventive pigment can be obtained by alternately coating the transparent carrier material with a metal oxide having a high refractive index and a metal oxide having a low refractive index according to the wet method, by hydrolysing the corresponding water-soluble, inorganic metal compounds, and separating, drying and optionally calcinating the obtained pigment.

Abstract: The invention relates to a liquid-crystalline medium based on a mixture of polar compounds of positive dielectric anisotropy, characterised in that it comprises one or more compounds of the general formula I in which R1, L1, L2, L3, L4, L5, L6, Z1, Z2, X, v and u are as defined in claim 1.

Abstract: The invention relates to the use of polypeptides with protein histidine phosphatase activity derived from mammalians, antibodies directed against them and DNA or RNA sequences complementary to mRNA sequences encoding polypeptides with protein histidine phosphatase activity for the modulation of ATP-citrate lyase and treatment of correlated pathophysiologic functions.

Abstract: The invention relates to compounds of the formula I and to a liquid-crystalline medium based on a mixture of polar compounds of positive dielectric anisotropy, characterized in that it comprises one or more compounds of the general formula I in which R, A1, A2, Z1, Y, Z, L1, L2 and m are as defined herein.

Abstract: EphA9 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing EphA9 polypeptides and polynucleotides in diagnostic assays.

Abstract: This invention relates to a method and device for drying cells for long-term storage by placing a preparation containing the micro-organisms into a re-sealable strip device which houses dry, water absorbent material and at least one protective substance, whereby the volume of the microorganism preparation and the amount and type of the drying preparation are chosen such that after the addition of the preparation of the micro-organisms the water absorbent preparation is able to absorb the water contained in the added sample and remain substantially dry, in so doing rendering the micro-organisms substantially dry.

Abstract: Modified interleukin-7 (IL-7) polypeptides are disclosed. The modified IL-7 polypeptides have alterations to one or more potential T-cell epitopes, thereby to reduce a T-cell response.

Abstract: In a device for connecting microcomponents, in particular microreactors, which preferably have a plate-shaped design and preferably consist of silicon, a sealing plate having apertures which correspond to apertures in the microcomponents is arranged between the microcomponents.

Abstract: The present invention relates to 5-aminomethylpyrazolo[4,3-d]pyrimidines of the general formula (I) in which the radicals R1 to R6 have the meaning indicated in the text. The compounds show phosphodiesterase V inhibition and can be employed for the treatment of conditions of the cardiovascular system and for the treatment of potency disorders.

Abstract: The invention relates to multilayered luster pigments based on metallic substrates, which are completely surrounded by a plurality of layers, where these layers comprise at least one layer pack (A) having a colorless dielectric layer of a material with a refractive index n of ?1.8, and a colorless dielectric layer of a material with a refractive index n of >1.8, and a selectively or non-selectively absorbent layer (B), and to a process for their production, and to their use.

Abstract: The invention relates to multireactive polymerizable mesogenic compounds of formula I R1—MG—R2I wherein R1, R2 and MG have the meaning given in claim 1, to a polymerizable mesogenic composition comprising at least two components, at least one which is a compound of formula I, to a linear or crosslinked polymer obtainable by polymerization of one or more compounds of formula I or of a polymerizable composition comprising one or more compounds of formula I and to the use of a compound of formula I, or a polymerizable composition or polymer obtainable thereof, in optical elements such as polarizers, optical retardation or compensation films, alignment layers, colour filters or holographic elements, in liquid crystal displays such as PDLC, polymer gel or polymer stabilized cholesteric texture (PSCT) displays, in adhesives, synthetic resins with anisotropic mechanical properties, cosmetics, diagnostics or liquid crystal pigments, for decorative and security applications, and for nonlinear optics or optical infor

Abstract: The invention relates to chiral compounds of formula (I) wherein R1, R2, A1, A2, X1, X2, Z3 and m have the meaning give in claim 1, to liquid crystalline mixtures comprising at least one chiral compound of formula (I), to chiral linear or crosslinked liquid crystalline polymers obtainable by polymerizing a polymerizable mixture comprising at least one chiral compound of formula (I), to the use of chiral compounds of formula (I) and mixtures and polymers obtained thereof in liquid crystal displays, active and passive optical elements, adhesives, synthetic resins with anisotropic mechanical properties, cosmetic and pharmaceutical compositions, diagnostics, liquid crystal pigments, for decorative and security applications, nonlinear optics, optical information storage or as chiral dopants, and to a liquid crystal display comprising a mixture comprising at least one chiral compound of formula (I).

Abstract: Isoquinoline derivatives of the general formula (I) in which X, Y, Z, R1, R2 and n are as defined in Patent Claim (1), and physiologically acceptable salts or solvates thereof, are integrin inhibitors and can be employed for combating thromboses, cardiac infarction, coronary heart diseases, arteriosclerosis, inflammation, tumors, osteoporosis, infections and restenosis after angioplasty or in pathological processes which are maintained or propagated by angiogenesis.

Abstract: The invention relates to a liquid-crystalline medium based on a mixture of polar compounds of positive dielectric anisotropy, characterised in that it comprises one or more ester compounds of the formula I and one or more compounds of the formula IA in which R1, R2, ring A, ring B, L1-6, Z1, Z2, X1 and X2 are as defined in claim 1.

Abstract: The invention relates to a process for the preparation of ?-aminosubstituted carboxylic acid amide compounds and/or their salts comprising reacting a carboxylic acid amide of a primary amine with a nitrosylating agent in the presence of a base followed by hydrolysis to give a hydroxy imino derivative followed by hydrogenation and if necessary converting a base or acid of the ?-aminosubstituted carboxylic acid amide into one of its salts.

Abstract: Nematic liquid-crystal mixtures comprising one or more compounds of the formula I in which R1 and R2 are as defined herein, are suitable for use in TN and STN liquid-crystal displays.

Abstract: The invention relates to the use of one or more compounds selected from compounds of formulae Ia and Ib, the physiologically compatible salts of compounds of formula Ia and Ib and the stereoisomer forms of compounds of formula La and Ib, wherein R1, R2, R3, R4 and n have the meaning cited in claim 1.

Abstract: The present invention relates to the isolation, purification and characterization of a hyaluronidase which derives from the tropical leech Hirudinaria manillensis. Therefore, according to this invention, the enzyme was called “manillase”. The invention is furthermore concerned with the recombinant method of production of manillase which includes the disclosure of DNA and amino acid sequences as well as of expression vectors and host systems. Finally, the invention relates to the use of manillase for therapeutic purposes, for example, for the treatment of myocardial diseases, thrombotic events and tumors.

Abstract: The present invention relates to a process for the preparation of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman, the enantiomers and its salts, characterised in that 5-(4-fluorophenyl)pyridine-3-carbaldehyde is reacted directly with aminomethylchroman or its salts under reducing conditions to give 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman, and the latter is, if desired, converted into one of its physiologically acceptable salts by treatment with an acid.

Abstract: A method for generating a 3-dimensional effect involves providing at least one first image layer of a chiral liquid crystal material, and at least one second image layer of a chiral liquid crystal material, wherein one of the first and second image layers reflects right-handed circularly polarised light and the other reflects left-handed circularly polarised light, is suitable creating a 3-dimensional image that can be used for decorative and security applications.